BEIJING & LONDON--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today ...
Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC BEIJING & LONDON — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results